4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-023011
Options or other derivatives
- Director acquired 14,117 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Miller-Rich Nancy Director | 2021-06-08 | Grant or award · Stock Option (Right to Buy) | +13,534 | 13,534 | D: show line 1 in the form | |||||
| Miller-Rich Nancy Director | 2021-06-08 | Grant or award · Stock Option (Right to Buy) | +583 | 583 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…